The short answer
Menopausal hormone therapy eases menopause symptoms but affects cancer risk. Combined estrogen-plus-progestin raises breast cancer risk; estrogen alone affects risks differently. Decisions balance symptom relief against risks with your doctor.
Menopausal hormone therapy is classified as a known human carcinogen (IARC Group 1).
People are mainly exposed by taking prescription hormone therapy for menopause symptoms.
It is most strongly linked to breast cancer (with combined therapy) and endometrial cancer (with estrogen alone).
A carcinogen classification describes hazard — whether something can cause cancer — not your personal risk at a given exposure.
Choose how you want to understand this
The full explanation.
The simple version
Menopausal hormone therapy (MHT) uses estrogen, sometimes with progestin, to ease menopause symptoms like hot flashes. It can raise the risk of some cancers while affecting others differently. This is a personal decision to make with your doctor, weighing benefits against risks.
What menopausal hormone therapy is
MHT replaces hormones that decline at menopause. "Combined" therapy uses estrogen plus progestin (for people with a uterus); "estrogen-only" therapy is used after hysterectomy. Large trials, including the Women's Health Initiative, shaped what we know about its risks and benefits.
How people are exposed
Common ways people come into contact with it:
- Taking prescription estrogen, with or without progestin, for menopause symptoms
- Pills, patches, gels, or other forms
- Use is guided by a doctor based on symptoms and health history
The cancer connection
Combined estrogen-plus-progestin therapy increases breast cancer risk. Estrogen-alone therapy increases the risk of endometrial cancer if the uterus is present (which is why progestin is added), while affecting other cancers differently. Some risks fall after stopping.
The International Agency for Research on Cancer (IARC), the cancer arm of the World Health Organization, places menopausal hormone therapy in Group 1, carcinogenic to humans — the strongest evidence category, meaning there is enough evidence that it can cause cancer in people. In the United States, the National Toxicology Program's Report on Carcinogens lists it as known to be a human carcinogen.
Hazard is not the same as risk
It helps to separate two ideas that are easy to mix up: hazard and risk. When an agency lists menopausal hormone therapy as a carcinogen, it is making a statement about hazard — whether the substance is capable of causing cancer under some conditions. It is not, by itself, a statement about your personal risk, which depends on how much you are exposed to, for how long, and other factors. Two substances in the same group can carry very different real-world risks. The label answers "can it cause cancer?" — not "how likely is it to cause cancer for me?"
How to lower your exposure
- Discuss your personal risks and benefits with your doctor
- Use the lowest effective dose for the shortest time that meets your needs
- Keep up with recommended breast and other screenings
- Report any unusual bleeding promptly
If you are looking at your overall cancer risk, small, steady steps add up. See our overview of cancer prevention and what raises cancer risk to put any single exposure in context.
The bottom line
Menopausal hormone therapy is a known human carcinogen (IARC Group 1). The most important thing you can do is understand where exposure comes from and take reasonable steps to reduce it, without losing sleep over a single label. Focus your energy on the biggest, most controllable risks in your own life.
Words to know
Tap any term to see what it means.
Common questions
▸Does menopausal hormone therapy cause cancer?
Yes. Menopausal hormone therapy is classified as a known human carcinogen, which means there is strong evidence it can cause cancer in people. How much any one person's risk rises depends on how much they are exposed to and for how long.
▸How are people exposed to menopausal hormone therapy?
Most exposure happens by taking prescription hormone therapy for menopause symptoms. This is a prescribed medical treatment, so decisions are made individually with a clinician.
▸Which cancers are linked to menopausal hormone therapy?
It is most strongly linked to breast cancer (with combined therapy) and endometrial cancer (with estrogen alone).
▸How can I reduce my exposure to menopausal hormone therapy?
The main steps are individualized decisions with your doctor and regular screening.
▸Does a carcinogen label mean I will get cancer?
No. A classification is about hazard — whether menopausal hormone therapy can cause cancer under some conditions — not a prediction that any one exposed person will develop cancer. Your actual risk depends on the amount and length of exposure and other factors.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Test your knowledge
0 of 4 answered
This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.